olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Tablets, for oral use Initial U.S. Approval: 2010
268d12e8-1cfc-4086-b613-8fd94f2d7c4e
HUMAN PRESCRIPTION DRUG LABEL
Oct 10, 2023
Par Pharmaceutical, Inc.
DUNS: 092733690
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Product Details
FDA regulatory identification and product classification information